DENV is a major public health problem worldwide, thus underlining the overall significance
of the proposed Program. The four dengue virus (DENV) serotypes (1–4) cause the most …

The contribution of T cells to the host response to dengue virus (DENV) infection is not well
understood. We previously demonstrated a protective role for CD8+ T cells during primary …

Infection with one of the four serotypes of dengue virus (DENV1–4) can result in a range of
clinical manifestations in humans, from dengue fever to the more serious dengue …

Dengue virus (DENV) is the etiologic agent of dengue fever, the most significant mosquito-
borne viral disease in humans. Up to 400 million DENV infections occur every year, and …

Infection with one of the four dengue virus serotypes (DENV1-4) presumably leads to
lifelong immunity against the infecting serotype but not against heterotypic reinfection …

Epidemiological studies suggest that India has the largest number of dengue virus infection
cases worldwide. However, there is minimal information about the immunological responses …

Dengue virus (DENV) has spread through most tropical and subtropical areas of the world
and represents a serious public health problem. The control of DENV infection has not yet …

Dengue virus (DENV) is the principal arthropod-borne viral pathogen afflicting human
populations. While repertoires of antibodies to DENV have been linked to protection or …

The interplay of different inflammatory cytokines induced during a dengue (DEN) virus
infection plays a role in either protection or increased disease severity. We measured the …

The target epitopes, serotype specificity, and cytolytic function of dengue virus-specific T
cells may influence their theoretical roles in protection against secondary infection as well as …